← Pulse/Companies/Compare
Apnimed
VS
Jupiter Neurosciences

Biotech comparison — funding, valuation, and investors, sourced from Value Add Pulse coverage.

A
Apnimed

Clinical-stage biotech developing Oxnimbi (AD109), the first investigational oral pill for obstructive sleep apnea.

3 Pulse stories
JN
Jupiter Neurosciences

Clinical-stage biotech developing JOTROL, a proprietary high-bioavailability resveratrol platform targeting neuroinflammation, mitochondrial dysfunction, and longevity indications including Parkinson's and Alzheimer's disease.

1 Pulse story
Total RaisedNot disclosed
Last ValuationNot disclosed
Biotech
Sector
Biotech
2017
Founded
—
Cambridge, Massachusetts
HQ
Jupiter, Florida
Public (APMD)
Status
Public (JUNS)
Apnimed investors
ShionogiColumbia Seligman Technology and Information FundAlpha Wave GlobalMorningside VenturesColumbia ManagementNexPoint Asset ManagementSectoral Asset Management
Jupiter Neurosciences investors
No investors on record.

Data from Value Add Pulse coverage and company research — see the full threads for Apnimed and Jupiter Neurosciences.